Australia's most trusted source of pharma news
Saturday, 23 February 2019
News Headlines
Contact Pharma in Focus
If you would like to know more about Pharma in Focus then write, email or phone us.
| Postal Address: | Suite 202 117 Old Pittwater Road Brookvale NSW 2100 |
| Advertising: | +61 2 9938 4381 |
| Editorial: | +61 2 9939 0981 |
| Subscriptions & Access: | +61 2 9939 1881 |
| Fax: | +61 2 9938 5681 | Email: | contact@pharmainfocus.com.au |
If you would like specific information then please fill in the form below and send it to us.
Pipeline Monitor
AbbVie advances RA drug
Uses priority review voucher for upadacitinib.
Uses priority review voucher for upadacitinib.
Top of the Hill
Power of a patient story
Why a story told well is pharma's most valuable message.
Why a story told well is pharma's most valuable message.
Approvals Action
AZ's new diabetes dose
Extended-release yet to be PBS listed.
Extended-release yet to be PBS listed.